Latest Insider Transactions at Cerevel Therapeutics Holdings, Inc. (CERE)
This section provides a real-time view of insider transactions for Cerevel Therapeutics Holdings, Inc. (CERE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cerevel Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cerevel Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 11
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Jun 15
2023
|
Marijn E Dekkers |
SELL
Open market or private sale
|
Indirect |
200,000
-33.2%
|
$6,800,000
$34.43 P/Share
|
|
Jun 07
2023
|
Bain Capital Investors LLC |
SELL
Other acquisition or disposition
|
Indirect |
432,627
-0.71%
|
-
|
|
Jun 07
2023
|
Adam Koppel |
SELL
Other acquisition or disposition
|
Indirect |
432,627
-0.71%
|
-
|
|
Jun 07
2023
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+50.0%
|
-
|
|
Jun 07
2023
|
Christopher R Gordon |
SELL
Other acquisition or disposition
|
Indirect |
432,627
-0.71%
|
-
|
|
Jun 07
2023
|
Christopher R Gordon |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+50.0%
|
-
|
|
Jun 07
2023
|
Gabrielle Sulzberger |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+6.42%
|
-
|
|
Jun 07
2023
|
Marijn E Dekkers |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+9.35%
|
-
|
|
Jun 07
2023
|
Norbert G Riedel |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+6.65%
|
-
|
|
Jun 07
2023
|
Deval L Patrick |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+50.0%
|
-
|
|
Jun 07
2023
|
Ruth Mckernan |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+50.0%
|
-
|
|
Jun 07
2023
|
Douglas E. Giordano |
BUY
Grant, award, or other acquisition
|
Direct |
3,282
+50.0%
|
-
|
|
Jun 02
2023
|
Mark Bodenrader |
SELL
Open market or private sale
|
Direct |
1,895
-25.55%
|
$60,640
$32.95 P/Share
|
|
Jun 01
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$1,600,000
$32.6 P/Share
|
|
Jun 01
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Jun 01
2023
|
Mark Bodenrader |
BUY
Exercise of conversion of derivative security
|
Direct |
4,733
+38.95%
|
-
|
|
May 04
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-53.81%
|
$1,600,000
$32.02 P/Share
|
|
May 04
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Apr 11
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$1,250,000
$25.06 P/Share
|
|
Apr 11
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Mar 03
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
3,000
-52.59%
|
$81,000
$27.19 P/Share
|
|
Mar 03
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+34.47%
|
$9,000
$3.5 P/Share
|
|
Mar 02
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
47,000
-94.56%
|
$1,269,000
$27.11 P/Share
|
|
Mar 02
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
47,000
+48.6%
|
$141,000
$3.5 P/Share
|
|
Feb 07
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-77.2%
|
$1,650,000
$33.31 P/Share
|
|
Feb 07
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Jan 05
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-54.76%
|
$1,500,000
$30.33 P/Share
|
|
Jan 05
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Dec 09
2022
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-75.33%
|
$1,300,000
$26.86 P/Share
|
|
Dec 09
2022
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
|
Nov 01
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-90.24%
|
$750,000
$30.0 P/Share
|
|
Nov 01
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+39.58%
|
$150,000
$6.89 P/Share
|
|
Oct 04
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-90.24%
|
$750,000
$30.0 P/Share
|
|
Oct 04
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+39.58%
|
$150,000
$6.89 P/Share
|
|
Sep 12
2022
|
Deval L Patrick |
SELL
Open market or private sale
|
Direct |
47,705
-100.0%
|
$1,431,150
$30.78 P/Share
|
|
Sep 12
2022
|
Deval L Patrick |
BUY
Exercise of conversion of derivative security
|
Direct |
47,705
+50.0%
|
$572,460
$12.62 P/Share
|
|
Sep 08
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
19,210
-100.0%
|
$614,720
$32.5 P/Share
|
|
Sep 08
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
19,210
+50.0%
|
$249,730
$13.17 P/Share
|
|
Aug 22
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
9,605
-100.0%
|
$307,360
$32.5 P/Share
|
|
Aug 22
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,605
+50.0%
|
$124,865
$13.17 P/Share
|
|
Aug 16
2022
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,425,000
+17.95%
|
$49,875,000
$35.0 P/Share
|
|
Aug 15
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
9,606
-100.0%
|
$326,604
$34.12 P/Share
|
|
Aug 15
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,606
+50.0%
|
$124,878
$13.17 P/Share
|
|
Aug 10
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
55,000
-75.05%
|
$2,200,000
$40.64 P/Share
|
|
Aug 10
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+39.18%
|
$330,000
$6.89 P/Share
|
|
Aug 08
2022
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$400,000
$40.0 P/Share
|
|
Aug 08
2022
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$130,000
$13.17 P/Share
|
|
Aug 08
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
19,211
-75.0%
|
$730,018
$38.63 P/Share
|
|
Aug 08
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
19,211
+50.0%
|
$249,743
$13.17 P/Share
|